Literature DB >> 6550616

Resistance of methicillin-resistant staphylococcus aureus to third-generation cephalosporins.

J K Collins, J T Mader, M T Kelly.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6550616     DOI： 10.1093/infdis/147.3.591

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  10 in total

1.  Rationale for eliminating Staphylococcus breakpoints for β-lactam agents other than penicillin, oxacillin or cefoxitin, and ceftaroline.

Authors:  Jennifer Dien Bard; Janet A Hindler; Howard S Gold; Brandi Limbago
Journal:  Clin Infect Dis       Date:  2014-01-22       Impact factor: 9.079

2.  Effect of inoculum size on in vitro susceptibility of methicillin-resistant Staphylococcus aureus to eighteen antimicrobial agents.

Authors:  C Watanakunakorn
Journal:  Eur J Clin Microbiol       Date:  1985-02       Impact factor: 3.267

3.  Susceptibility of methicillin-resistant Staphylococcus aureus to the selenium-containing compound 2-phenyl-1,2-benzoisoselenazol-3(2H)-one (PZ51).

Authors:  R Nozawa; T Yokota; T Fujimoto
Journal:  Antimicrob Agents Chemother       Date:  1989-08       Impact factor: 5.191

4.  Unusual susceptibility of methicillin-resistant Staphylococcus aureus to erythromycin, clindamycin, gentamicin, and tetracycline at 30 degrees C but not at 35 degrees C.

Authors:  W D Welch; P M Southern
Journal:  J Clin Microbiol       Date:  1984-06       Impact factor: 5.948

5.  Occurrence of a beta-lactam-inducible penicillin-binding protein in methicillin-resistant staphylococci.

Authors:  K Ubukata; N Yamashita; M Konno
Journal:  Antimicrob Agents Chemother       Date:  1985-05       Impact factor: 5.191

6.  Comparative in vitro inhibitory and killing activity of cefpirome, ceftazidime, and cefotaxime against Pseudomonas aeruginosa, enterococci, Staphylococcus epidermidis, and methicillin-susceptible and -resistant and tolerant and nontolerant Staphylococcus aureus.

Authors:  E J Goldstein; D M Citron
Journal:  Antimicrob Agents Chemother       Date:  1985-07       Impact factor: 5.191

7.  Efficacy of penicillin G, flucloxacillin, cefazolin, fusidic acid, vancomycin, rifampicin and fosfomycin in muscular infections in mice due to Staphylococcus aureus.

Authors:  R Haag
Journal:  Infection       Date:  1986 Jan-Feb       Impact factor: 3.553

8.  In vitro activities of a novel cephalosporin, CB-181963 (CAB-175), against methicillin-susceptible or -resistant Staphylococcus aureus and glycopeptide-intermediate susceptible staphylococci.

Authors:  Vanthida Huang; William J Brown; Michael J Rybak
Journal:  Antimicrob Agents Chemother       Date:  2004-07       Impact factor: 5.191

9.  TOC-39, a novel parenteral broad-spectrum cephalosporin with excellent activity against methicillin-resistant Staphylococcus aureus.

Authors:  H Hanaki; H Akagi; Y Masaru; T Otani; A Hyodo; K Hiramatsu
Journal:  Antimicrob Agents Chemother       Date:  1995-05       Impact factor: 5.191

10.  Identification of Functional Regulatory Residues of the β -Lactam Inducible Penicillin Binding Protein in Methicillin-Resistant Staphylococcus aureus.

Authors:  Andreas N Mbah; Raphael D Isokpehi
Journal:  Chemother Res Pract       Date:  2013-07-29
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.